European Council President Donald Tusk discusses Brexit in Valletta, Malta, on March 31.
Darrin Zammit Lupi / Reuters
—The EU’s draft on Brexit talks propose a “phased approach,” suggesting talks on a trade deal with the U.K. can begin once there’s enough progress on a financial settlement.
—Mike Flynn offers to be interviewed in exchange for immunity from prosecution, the Wall Street Journal and other are reporting. More here
—We’re tracking the news stories of the day below. All updates are in Eastern Daylight Time (GMT -4).
President Trump signed two executive orders on Friday, aimed at assessing the fairness of U.S. trade deals. The move represents a more cautious approach from when Trump, as presidential candidate, promised to scrap the North American Free Trade Agreement (NAFTA), which he called “the worst trade deal ever.” The first order Trump signed calls for a 90-day study to look country-by-country, product-by-product, at abuses that contribute to the U.S. trade deficit. The study would serve as a template for rule- and decision-making when the administration evaluates how to reorganize trade deals. The second order will step up duties collected from countries the U.S. finds to be dumping products at below production costs, often done with heavy subsidies from their governments. The orders come a week ahead of Trump’s meeting with President Xi Jinping of China, which Trump has accused of taking advantage of the U.S. Trump has called the U.S. trade deficit—more than $500 billion last year—a job-killer, and has said he will renegotiate deals like NAFTA to put American interests first. But more so than trade deals, economists have pointed to the increased robotization of factories as the major cause for lost factory jobs. At the signing ceremony Friday, after taking a few questions from the media, Trump abruptly left without actually signing the order. Vice President Mike Pence instead picked up the document and chased after the president.
The meeting next week with China will be a very difficult one in that we can no longer have massive trade deficits...
New York Mayor De Blasio Plans to Close Rikers Island Jail Within 10 Years
Lucas Jackson / Reuters
New York City Mayor Bill de Blasio announced Friday plans to shutter the Rikers Island jail complex within the next decade in a bid to end the era of mass incarceration in the city.
Rikers Island is an expression of a national problem. The mass incarceration era did not begin in New York City but it’s going to end here.
Closing the 85-year-old facility will be a “long and arduous” process, de Blasio said in a statement, adding “our success in reducing crime and reforming our criminal justice system has paved a path off Rikers Island and toward community-based facilities capable of meeting our criminal justice goals.” De Blasio said the project would require cutting the jail’s nearly 10,000-person population in half, as well as constructing several smaller facilities to replace it. The announcement follows the formation last year of an independent panel commissioned to examine the facility, which, as The New York Times reports, recommended the jail be demolished and replaced with new jails built in each of the city’s five boroughs. More details from the commissions findings are expected to be announced Sunday.
A Federal Judge Approves a $25 Million Trump University Settlement
Carlos Barria / Reuters
A federal judge on Friday approved a deal for President Trump to pay $25 million to settle lawsuits against him over Trump University, the defunct real-estate education program created by Trump. The ruling, by U.S. District Court Judge Gonzalo Curiel in the Southern District of California, ends seven years of legal battles, with class-action suits in New York and California. The cases came to national attention during Trump’s election campaign, with plaintiffs saying they’d signed up to learn Trump’s real-estate investment secrets, but instead forked out thousands of dollars for worthless information that could be found free online. Trump had refused to settle the suits, and even promised to reopen the university once he won the court battle. At one point, he complained that Curiel could not possibly oversee the case impartially, because of the Indiana-born judge’s Mexican heritage. Trump later apologized for this comment, reversed his stance on the lawsuit, and after he won the election in November agreed to settle for $25 million. That figure comes to about 90 percent of the money his university took from customers. Not everyone is happy, and there were two plaintiffs who objected to the settlement, one on the grounds that Trump owed them an apology.
Germany Says NATO's Spending Target Neither 'Reachable nor Desirable'
U.S. Secretary of State Rex Tillerson speaks at NATO’s headquarters in Brussels, Belgium on March 31, 2017. (Virginia Mayo / Reuters)
Germany called the 2-percent spending goal for all NATO allies neither “reachable nor desirable” Friday in response to repeated calls by the U.S. for members of the military alliance to meet their financial commitments. “Two percent would mean military expenses of some 70 billion euros,” Sigmar Gabriel, Germany’s foreign minister, said at a NATO meeting in Brussels, where U.S. Secretary of State Rex Tillerson was in attendance. “I don’t know any German politician who would claim that is reachable nor desirable.” His remarks follow repeated demands by the U.S. that NATO members fulfill their treaty obligations and contribute 2 percent of their gross domestic product to defense spending by 2024—a goal that five of the NATO’s 28 members have met. Germany spends about 1.2 percent of its GDP on defense. Tillerson said Friday all allies should by May “either met the pledge guidelines or will have developed plans that clearly articulate how … the pledge will be fulfilled.” He also reaffirmed the U.S. government’s commitment to the alliance—one which President Trump has previously criticized as “obsolete,” having at one point appeared to suggest that U.S. commitment to the body should be predicated upon its members’s defense spending. But Trump reaffirmed his “strong support for NATO” this month during a joint news conference with German Chancellor Angela Merkel, who also reaffirmed support for NATO and Germany’s commitment to the the 2 percent spending target. She said: “Last year we increased our defense spending by 8 percent, and we’re going to work together again and again on this.”
The Wall Street Journal and others reported last night that Mike Flynn, President Trump’s national-security adviser, old the FBI and congressional investigators he is willing to be interviewed in exchange for immunity from prosecution. As Matt Ford wrote: “Why does someone request immunity from prosecution before speaking with federal investigators? That question will likely consume Washington in the weeks ahead after Thursday night’s bombshell...” Robert Kelner, Flynn’s attorney, said: “General Flynn certainly has a story to tell, and he very much wants to tell it, should the circumstances permit.” But The New York Times cited an unnamed congressional official as saying investigators are not willing to broker a deal “until they are further along in their inquiries and they better understand what information Mr. Flynn might offer as part of a deal.” But as Matt wrote last night: “A request for immunity isn’t an admission of guilt or wrongdoing. It may be sought by witnesses who fear that their words could be used against them, as a condition of their testimony. … But the move could also be a purely prophylactic measure.”
The European Union is suggesting a “phased approach” to Brexit in which it will discuss a trade deal with the U.K. only when there’s sufficient progress made on the nature of their separation. The EU’s draft plan, which was released today in Brussels, must now be approved by the bloc’s 27 other members (the U.K. remain the 28th member until its separation from the EU is final; the process is expected to take at least two years). The release of the plan comes two days after the U.K. invoked Article 50 of the Lisbon treaty, the process by which Brexit negotiations formally begin. The U.K. wants talks on its exit and trade relations to be discussed simultaneously. Donald Tusk, the European Council president, said in Malta that “will not happen.” “Only once we have achieved sufficient progress on the withdrawal can we discuss the framework for our future relationship,” he said.
In his response to an adverse decision by the Supreme Court, the former president previewed an argument he’s likely to keep using.
Former President Donald Trump faces various legal and political challenges, but few seem to have gotten him as agitated as a routine, expected, unsigned decision by the Supreme Court on Monday.
Trump had already lost a bid to prevent Manhattan District Attorney Cy Vance Jr. from acquiring his financial records via subpoena. The former president then sought a stay while he searched for other means to stall. As anticipated, the justices rejected the request. Trump then issued one of just a handful of public statements he’s issued since leaving office, blasting “the Continuing Political Persecution of President Donald J. Trump.”
His vehemence is part of a long-running pattern: Trump dislikes all investigations, but nothing rattles him like probes into his finances. (When he tried to fire Special Counsel Robert Mueller, it was because of a report that Mueller had subpoenaed his financial records.) We can guess at the reasons. First, Trump is extremely defensive about anything that might imply he is not as rich as he claims. Second, there is much to suggest that Trump might have committed financial crimes.
The virus can take many paths to reinvading a person’s body. Most of them shouldn’t scare us.
On its face, reinfection appears to be a straightforward term. It is literally “infection, again”—a recovered person’s second dalliance with the same microbe. Long written into the scientific literature of infectious disease, it is a familiar word, innocuous enough: a microbial echo, an immunological encore act.
But thanks to the pandemic, reinfection has become a semantic and scientific mess.
Newly saddled with the baggage of COVID-19, reinfection has taken on a more terrifying aspect, raising the specter of never-ending cycles of disease. It has sat at the center of debates over testing, immunity, and vaccines; its meaning muddled by ominous headlines, it has become wildly misunderstood. When I ask immunologists about reinfection in the context of the coronavirus, many sigh.
An uncertain spring, an amazing summer, a cautious fall and winter, and then, finally, relief.
Updated at 10:12 a.m. ET on February 24, 2021.
The end of the coronavirus pandemic is on the horizon at last, but the timeline for actually getting there feels like it shifts daily, with updates about viral variants, vaccine logistics, and other important variables seeming to push back the finish line or scoot it forward. When will we be able to finally live our lives again?
Pandemics are hard to predict accurately, but we have enough information to make some confident guesses. A useful way to think about what’s ahead is to go season by season. In short: Life this spring will not be substantially different from the past year; summer could, miraculously, be close to normal; and next fall and winter could bring either continued improvement or a moderate backslide, followed by a near-certain return to something like pre-pandemic life.
She lived with us for 56 years. She raised me and my siblings without pay. I was 11, a typical American kid, before I realized who she was.
The ashes filled a black plastic box about the size of a toaster. It weighed three and a half pounds. I put it in a canvas tote bag and packed it in my suitcase this past July for the transpacific flight to Manila. From there I would travel by car to a rural village. When I arrived, I would hand over all that was left of the woman who had spent 56 years as a slave in my family’s household.
The Netflix neo-noir isn’t just about a merciless scammer; it’s about the broken bureaucracies that enable her abuse.
Psychiatric hospitals, nursing homes, and other long-term-care facilities have served as chilling backdrops to some of film’s most arresting psychological thrillers. But the foreboding lighthouse of Shutter Island and the macabre, labyrinthine hospital of One Flew Over the Cuckoo’s Nest pale in comparison with both movies’ animating horrors: the wretched treatment of the people trapped within. These works dramatize the cruelties that hospital administrators and caretakers exact upon their patients, especially those who have been admitted against their will, with Hitchcockian dread. In doing so, they challenge conventional wisdom about mental illness, authority, and the ethics of condemning people to isolation.
A new docuseries about the molestation allegation against Woody Allen is determinedly focused on making its case, sometimes at the expense of nuance.
Updated at 3:33 p.m. ET on February 24, 2021.
Watching Allen v. Farrow, HBO’s new four-part miniseries about the 29-year-old allegations of child molestation against the director Woody Allen, I kept having a feeling that I couldn’t entirely identify. Since revelations about Harvey Weinstein emerged in late 2017—broken, in part, by Allen’s son, Ronan Farrow—harrowing stories about abusive men in the workplace have been reported one after another. But the story of Dylan Farrow, who was 7 years old in 1992, when she told her mother that her father had sexually abused her, is different, an allegation of domestic trauma that’s been weaponized by interested parties again and again. The feeling I had, I eventually realized, was one of wanting to look away. Not because I don’t believe Dylan (I do), or because I believe Allen’s work is so valuable that her testimony is worth shunting aside (I don’t, and no one’s is). It’s queasier than that: a nagging sense that, at this point, there’s still no way for Dylan to tell her story without it being exploited.
At some point—maybe even soon—the emergency phase of the pandemic will end. But what, exactly, is that magic threshold?
In the middle of January, the deadliest month of the pandemic, one day after inauguration, the Biden administration put out a comprehensive national strategy for “beating COVID-19.” The 200-page document includes many useful goals, such as “Restore trust with the American people” and “Mount a safe, effective, and comprehensive vaccination campaign.” But nowhere does it give a quantitative threshold for when it will be time to say, “Okay, done—we’ve beaten the pandemic.”
A month later, it’s time to get specific. The facts are undeniable: The seven-day average of new cases in the United States has fallen by 74 percent since their January peak, hospitalizations have gone down by 58 percent, and deaths have dropped by 42 percent. Meanwhile, more than 60 million doses of vaccine have gone into American arms. At some point—maybe even some point relatively soon—the remaining emergency measures that were introduced in March 2020 will come to an end. But when, exactly, should that happen?
Side effects are just a sign that protection is kicking in as it should.
At about 2 a.m. on Thursday morning, I woke to find my husband shivering beside me. For hours, he had been tossing in bed, exhausted but unable to sleep, nursing chills, a fever, and an agonizingly sore left arm. His teeth chattered. His forehead was freckled with sweat. And as I lay next to him, cinching blanket after blanket around his arms, I felt an immense sense of relief. All this misery was a sign that the immune cells in his body had been riled up by the second shot of a COVID-19 vaccine, and were well on their way to guarding him from future disease.
Side effects are a natural part of the vaccination process, as my colleague Sarah Zhang has written. Not everyone will experience them. But the two COVID-19 vaccines cleared for emergency use in the United States, made by Pfizer/BioNTech and Moderna, already have reputations for raising the hackles of the immune system: In both companies’clinical trials, at least a third of the volunteers ended up with symptoms such as headaches and fatigue; fevers like my husband’s were less common.
Biology textbooks tell us that lichens are alliances between two organisms—a fungus and an alga. They are wrong.
In 1995, if you had told Toby Spribille that he’d eventually overthrow a scientific idea that’s been the stuff of textbooks for 150 years, he would have laughed at you. Back then, his life seemed constrained to a very different path. He was raised in a Montana trailer park, and homeschooled by what he now describes as a “fundamentalist cult.” At a young age, he fell in love with science, but had no way of feeding that love. He longed to break away from his roots and get a proper education.
At 19, he got a job at a local forestry service. Within a few years, he had earned enough to leave home. His meager savings and nonexistent grades meant that no American university would take him, so Spribille looked to Europe.
Financial confessionals reveal that income inequality and geographic inequality have normalized absurd spending patterns.
The hypothetical couple were making $350,000 a year and just getting by, their income “barely” qualifying them as middle-class. Their budget, posted in September, showed how they “survived” in a city like San Francisco, spending more than $50,000 a year on child care and preschool, nearly $50,000 a year on their mortgage, and hefty amounts on vacations, entertainment, and a weekly date night—even as they saved for retirement and college in tax-advantaged accounts.
The internet, being the internet, responded with some combination of howling, baying, pitchfork-jostling, and scoffing. Representative Alexandria Ocasio-Cortez of New York quipped that the thing the family was struggling with was math. Gabriel Zucman, a leading scholar of wealth and inequality, described the budget as laughable, while noting that it showed how much money consumption taxes could raise.
/media/None/YSerhan_Headshot-1/original.png)
/media/img/mt/2021/02/PandemicTimeEND2/original.png)
/media/img/mt/2021/02/Screen_Shot_2021_02_01_at_2.00.32_PM/original.png)
/media/img/mt/2016/07/8332405501_a8455b9aca_o/original.png)
/media/video/img/upload/2012/12/screen-shot-2012-12-18-at-25812-pm/original.png)
